Collaborative Medicinal Development
About:
Collaborative Medicinal Development is a privately-held biopharmaceutical company.
Website: https://colmeddev.com/
Top Investors: Cthulhu Ventures, FightMND
Description:
Collaborative Medicinal Development is a privately-held biopharmaceutical company developing innovative therapies for neurodegenerative diseases. The Company's lead drug, CuATSM, was licensed from the University of Melbourne and entered clinical trials in ALS and Parkinson's disease in 2017.
Total Funding Amount:
1M AUD
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Sausalito, California, United States
Founded Date:
2012-01-01
Contact Email:
ClinicalOperations(AT)ColMedDev.com
Founders:
Number of Employees:
11-50
Last Funding Date:
2019-04-17
IPO Status:
Private
Industries:
© 2025 bioDAO.ai